Generics Advocates: Tariffs Won’t Bring Drug, API Production Onshore

AMELIA ISLAND, FL -- Tariffs won’t be enough to bring generic drug and active pharmaceutical ingredient (API) manufacturing to the United States, generic advocates said at the Association for Accessible Medicines (AAM) conference this week, despite the Trump administration’s tough trade policy. They argued the low cost of labor abroad and limited capacity in the United States means tariffs won’t shift production onshore, risking increased drug shortages without any growth in the domestic industry. AAM CEO John Murphy has previously...